Relmada Therapeutics, Inc. (RLMD) News
Follow Relmada Therapeutics, Inc. (RLMD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Relmada Therapeutics to participate at Wells Fargo 21st Healthcare Conference
Relmada Therapeutics said senior management will participate in the Wells Fargo 21st Annual Healthcare Conference.
EQUITY | Sep 01, 2026, 12:07 PM UTC
L
RLMD - Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
RLMD - Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
EQUITY | Sep 01, 2026, 12:00 PM UTC
M
RLMD: HC Wainwright Initiates Buy
HC Wainwright & Co. initiates coverage on Relmada Therapeutics with a buy rating and a price target of $12
EQUITY | Jun 18, 2026, 10:55 AM UTC